OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 373 citing articles:

Endoplasmic reticulum stress signals in the tumour and its microenvironment
Xi Chen, Juan R. Cubillos‐Ruiz
Nature reviews. Cancer (2020) Vol. 21, Iss. 2, pp. 71-88
Open Access | Times Cited: 837

Regulation of PD-L1 expression in the tumor microenvironment
Ming Yi, Mengke Niu, Linping Xu, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 442

MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases
Xiaolin Wang, Yong He, Bryan Mackowiak, et al.
Gut (2020) Vol. 70, Iss. 4, pp. 784-795
Closed Access | Times Cited: 369

The significance of exosomes in the development and treatment of hepatocellular carcinoma
Xin Li, Chuanyun Li, Ping Zhang, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 365

Isolation and characterization of exosomes for cancer research
Le Zhu, Haoting Sun, Shun Wang, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 344

Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
Hao Zhang, Ziyu Dai, Wantao Wu, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 340

The role of exosomal PD-L1 in tumor progression and immunotherapy
Feiting Xie, Mengxue Xu, Jian Lu, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 285

Role of exosomal non-coding RNAs from tumor cells and tumor-associated macrophages in the tumor microenvironment
Zijie Xu, Yi Chen, Ling Ma, et al.
Molecular Therapy (2022) Vol. 30, Iss. 10, pp. 3133-3154
Open Access | Times Cited: 184

Endoplasmic reticulum stress in liver diseases
Amir Ajoolabady, Neil Kaplowitz, Cynthia Lebeaupin, et al.
Hepatology (2022) Vol. 77, Iss. 2, pp. 619-639
Open Access | Times Cited: 179

Endoplasmic reticulum stress-mediated cell death in liver injury
Jian Zhang, Jiafu Guo, Nannan Yang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 12
Open Access | Times Cited: 166

Inhibition of Glutamine Utilization Synergizes with Immune Checkpoint Inhibitor to Promote Antitumor Immunity
Jun‐Kyu Byun, Mihyang Park, Seunghyeong Lee, et al.
Molecular Cell (2020) Vol. 80, Iss. 4, pp. 592-606.e8
Open Access | Times Cited: 141

Exosomes and extracellular vesicles: Rethinking the essential values in cancer biology
Akira Yokoi, Takahiro Ochiya
Seminars in Cancer Biology (2021) Vol. 74, pp. 79-91
Open Access | Times Cited: 106

Immune checkpoint inhibitor resistance in hepatocellular carcinoma
Zhijie Wang, Yichuan Wang, Peng Gao, et al.
Cancer Letters (2022) Vol. 555, pp. 216038-216038
Closed Access | Times Cited: 80

Regulatory mechanisms of PD-1/PD-L1 in cancers
Xin Lin, Kuan Kang, Pan Chen, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 79

Cancer cell-intrinsic XBP1 drives immunosuppressive reprogramming of intratumoral myeloid cells by promoting cholesterol production
Zaili Yang, Yazhen Huo, Shixin Zhou, et al.
Cell Metabolism (2022) Vol. 34, Iss. 12, pp. 2018-2035.e8
Open Access | Times Cited: 77

Reactive oxygen species reprogram macrophages to suppress antitumor immune response through the exosomal miR-155-5p/PD-L1 pathway
Xiang Li, Shaomin Wang, Wei Mu, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 73

ALKBH5/MAP3K8 axis regulates PD-L1+ macrophage infiltration and promotes hepatocellular carcinoma progression
Yu You, Diguang Wen, Lu Zeng, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 13, pp. 5001-5018
Open Access | Times Cited: 71

Exosomal miRNA-mediated intercellular communications and immunomodulatory effects in tumor microenvironments
Howida M. Nail, Chien‐Chih Chiu, Chung‐Hang Leung, et al.
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 60

MicroRNAs as regulators of immune checkpoints in cancer immunotherapy: targeting PD-1/PD-L1 and CTLA-4 pathways
Arefeh Zabeti Touchaei, Sogand Vahidi
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 29

Tumor immune escape: extracellular vesicles roles and therapeutics application
Mahdi Ahmadi, Reza Abbasi, Jafar Rezaie
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 22

Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside
Yue Yin, Weibo Feng, Jie Chen, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 17

Decoding the spatiotemporal heterogeneity of tumor-associated macrophages
Xiangyuan Chu, Yu Tian, Chao Lv
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 15

Page 1 - Next Page

Scroll to top